These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6386282)

  • 1. Autoimmunity in liver disease.
    McFarlane IG
    Clin Sci (Lond); 1984 Dec; 67(6):569-78. PubMed ID: 6386282
    [No Abstract]   [Full Text] [Related]  

  • 2. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigens of the human liver.
    McFarlane IG; Wojcicka BM; Williams R
    Clin Exp Immunol; 1980 Apr; 40(1):1-7. PubMed ID: 6156044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specificity of 2 types of antibodies against liver cell membrane (anti-LM and anti-LSP) in sera of patients with chronic active liver diseases].
    Tsuji T
    Nihon Shokakibyo Gakkai Zasshi; 1983 Mar; 80(3):901. PubMed ID: 6865080
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of liver membrane antigens as targets in autoimmune type liver disease.
    Meyer zum Büschenfelde KH; Hütteroth TH; Manns M; Möller B
    Springer Semin Immunopathol; 1980 Dec; 3(3):297-315. PubMed ID: 7022712
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.
    Manns M; Meyer zum Büschenfelde KH; Hess G
    Gut; 1980 Nov; 21(11):955-61. PubMed ID: 7450561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symposium on autoimmune diseases. Studies on mechanism of liver cell damage and significances of autoantibodies in autoimmune liver diseases].
    Nagashima H
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):598-9. PubMed ID: 4565167
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.
    Watanabe Y; Kawakami H; Kawamoto H; Ikemoto Y; Masuda K; Takezaki E; Nakanishi T; Kajiyama G; Takeno H
    Clin Exp Immunol; 1987 Jan; 67(1):105-13. PubMed ID: 3621670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.
    Uibo RM; Helin HJ; Krohn KJ
    Clin Exp Immunol; 1982 May; 48(2):505-12. PubMed ID: 7105494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro.
    Poralla T; Ramadori G; Dienes HP; Manns M; Gerken G; Dippold W; Hütteroth TH; Meyer zum Büschenfelde KH
    J Hepatol; 1987 Jun; 4(3):373-80. PubMed ID: 3598165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of autoimmune liver disease.
    Meyer zum Büschenfelde KH; Manns M
    Semin Liver Dis; 1984 Feb; 4(1):26-35. PubMed ID: 6231727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of the theories of the chronicity of liver diseases].
    Damianov B
    Vutr Boles; 1981; 20(2):25-32. PubMed ID: 7020250
    [No Abstract]   [Full Text] [Related]  

  • 14. [The development and a clinical trial of an erythrocytic diagnostic agent for determining antibodies to the liver-specific lipoprotein].
    Zhavoronok SV; Semenov VM; Chertoritskaia ML; Kalinin AL
    Lab Delo; 1989; (8):56-60. PubMed ID: 2477633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to liver-specific lipoprotein in children with chronic liver disease due to "autoimmune" chronic active hepatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency.
    Larcher VF; Macdonald A; Vegnente A; Mowat AP; Eddleston AL; Williams R
    J Pediatr Gastroenterol Nutr; 1984 Nov; 3(5):728-33. PubMed ID: 6334153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to liver cytoplasmic protein complex in chronic hepatic disease.
    Meliconi R; Facchini A; Miglio F; Gasbarrini G
    Lancet; 1987 Mar; 1(8534):683-4. PubMed ID: 2882101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of liver membrane autoantibodies detected with rat liver section and Chang liver cells].
    Sugiura M; Tomiyama H; Tsukada M; Shizawa M; Maruyama S; Ishido T; Hino K; Yoshiwara N
    Rinsho Byori; 1986 Mar; 34(3):319-24. PubMed ID: 3712793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of autoimmune hepatitis with hot labelled liver specific antigen.
    Fehér J; Filipp G; Kocsár L; Mohari K; Toncsev H; Fehér E; Biro G
    Clin Exp Immunol; 1984 Feb; 55(2):360-8. PubMed ID: 6697567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspect of liver and liver diseases].
    Onji M
    Nihon Shokakibyo Gakkai Zasshi; 2004 Feb; 101(2):146-54. PubMed ID: 15011438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.